| 000 | 01857 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517090314.0 | ||
| 264 | 0 | _c20170310 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1791-2423 | ||
| 024 | 7 |
_a10.3892/ijo.2016.3470 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTakeda, Tomoya | |
| 245 | 0 | 0 |
_aMangiferin enhances the sensitivity of human multiple myeloma cells to anticancer drugs through suppression of the nuclear factor κB pathway. _h[electronic resource] |
| 260 |
_bInternational journal of oncology _cJun 2016 |
||
| 300 |
_a2704-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelphalan _xpharmacology |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aVincristine _xpharmacology |
| 650 | 0 | 4 |
_aXanthones _xpharmacology |
| 700 | 1 | _aTsubaki, Masanobu | |
| 700 | 1 | _aKino, Toshiki | |
| 700 | 1 | _aKawamura, Ayako | |
| 700 | 1 | _aIsoyama, Shota | |
| 700 | 1 | _aItoh, Tatsuki | |
| 700 | 1 | _aImano, Motohiro | |
| 700 | 1 | _aTanabe, Genzoh | |
| 700 | 1 | _aMuraoka, Osamu | |
| 700 | 1 | _aMatsuda, Hideaki | |
| 700 | 1 | _aSatou, Takao | |
| 700 | 1 | _aNishida, Shozo | |
| 773 | 0 |
_tInternational journal of oncology _gvol. 48 _gno. 6 _gp. 2704-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/ijo.2016.3470 _zAvailable from publisher's website |
| 999 |
_c25884287 _d25884287 |
||